TORONTO, Aug. 5 /CNW/ - Biosign Technologies Inc. (CNSX: BIO) ("Biosign", or the "Company") announces that it has entered into a services agreement with The Trout Group LLC ("the Trout Group"), a leading New York-based investor relations and strategic advisory firm. The Trout Group will provide investor relations and advisory services for Biosign effective August 6, 2010. The term of the initial engagement is for one year.
With more than 60 current clients, the Trout Group provides investor relations and advisory services exclusively for the life sciences industry. The Trout Group will be assisting Biosign with its corporate goal to broaden the Company's exposure to institutional investors.
The Trout Group is not related to Biosign, nor do they have any interest, directly or indirectly, in the Company's securities.
About Biosign Technologies Inc.
Biosign Technologies Inc. (CNSX: BIO) provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT(R) medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit www.biosign.com.
About the Trout Group LLC
The Trout Group is a leading investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1996, the Trout Group has been providing healthcare and biotechnology companies with expert investor relations counsel and access to the institutional investment community. Based on our experience in the biotechnology, pharmaceuticals, medical technology and life science technology sectors, the Trout Group offers our clients the knowledge to clarify investment themes and reach the proper target audience. The Trout Group's global reach extends through a network of offices and contacts in all major financial centers, helping our clients find the right investors. The Trout Group - Relationship Capital. For additional information, please visit www.troutgroup.com.
The CNSX has neither approved nor disapproved the contents of this press release.
SOURCE Biosign Technologies Inc.
For further information: For further information: Alan S. Roemer, SVP, The Trout Group LLC, 646 378 2900, email@example.com; Radu Leca, President & CEO, Biosign Technologies Inc., Phone: (416) 218-9800 ext. 222, Email: firstname.lastname@example.org